Yoshiya Tanaka | Medicine and Dentistry | Best Researcher Award

Posted on 29/03/202529/03/2025 by Book of Award

Prof. Yoshiya Tanaka | Medicine and Dentistry | Best Researcher Award

University of Occupational and Environmental Health | Japan

Author Profile

🎓 Early Academic Pursuits

Prof. Yoshiya Tanaka embarked on his academic journey at the University of Occupational and Environmental Health, Japan (UOEH), where he earned his MD in 1984. His thirst for knowledge and commitment to medical research led him to pursue a PhD at the Graduate School of Medical Science, UOEH, which he completed in 1988. This strong academic foundation laid the groundwork for his exceptional career in internal medicine and rheumatology.

🌟 Professional Endeavors

Prof. Tanaka’s illustrious career began with a prestigious opportunity as a Visiting Fellow in the Experimental Immunology Branch at the National Cancer Institute, NIH, USA, from 1989 to 1992. Upon returning to Japan, he rapidly ascended the academic ladder, becoming a Professor and Chairman of the First Department of Internal Medicine at UOEH in 2000. His leadership and expertise earned him the role of Dean of the Graduate School of Medical Science at UOEH in 2017, followed by his appointment as Director of the International Center at UOEH in 2022.

🔬 Contributions and Research Focus

Prof. Tanaka has dedicated his career to advancing the field of rheumatology, clinical immunology, and inflammatory diseases. His research primarily focuses on rheumatoid arthritis, systemic lupus erythematosus, and novel therapeutic approaches, including Janus kinase (JAK) inhibitors and biologic therapies. His groundbreaking work on cytokine-targeting therapies has significantly influenced treatment strategies for autoimmune diseases. As a key member of multiple scientific societies, he has contributed to the Japanese College of Rheumatology (JCR), the Japanese Society of Clinical Immunology, and the Asia Pacific League of Associations for Rheumatology (APLAR). His editorial contributions include serving as an editor or associate editor for prestigious journals such as The Lancet Rheumatology, Annals of Rheumatic Diseases, and Arthritis Research & Therapy.

🏆 Accolades and Recognition

Prof. Tanaka's contributions to rheumatology and immunology have been recognized through numerous awards. In 2003, he received the Academic Award from the Japanese Society of Bone and Mineral Research (JSBMR), followed by the President Award from the Japanese College of Rheumatology in 2008. His outstanding research was acknowledged globally when he was honored with the Congress Award from the European Alliance of Associations for Rheumatology (EULAR) in 2009. In 2023, his lifelong contributions earned him the prestigious Honorary Award from EULAR.

🔍 Impact and Influence

With over 1,067 publications in English and an impressive h-index of 117, Prof. Tanaka's research has left an indelible mark on the field of rheumatology. His total impact factor of 6,402 underscores the significance of his work in shaping clinical practices worldwide. His seminal studies, including those published in Nature, The New England Journal of Medicine, and The Lancet, have influenced treatment protocols and deepened the understanding of inflammatory and autoimmune diseases. As a mentor, he has guided numerous young researchers, fostering the next generation of scientists and clinicians in Japan and beyond. His involvement in international collaborations has further solidified his role as a global leader in rheumatology research.

🌱 Legacy and Future Contributions

Prof. Tanaka’s legacy is defined by his relentless pursuit of scientific discovery and his commitment to improving patient care. His work in cytokine-targeted therapies and JAK inhibitors has paved the way for more effective and personalized treatments for autoimmune diseases. As he continues to lead groundbreaking research and mentor future medical professionals, his impact on the field will endure for generations to come. With his ongoing roles at UOEH and leadership positions in international rheumatology organizations, Prof. Tanaka remains at the forefront of medical innovation. His future contributions promise to further revolutionize treatment paradigms and enhance the quality of life for patients worldwide.

Publications

Article: Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness
Authors: S. Kubo, Y. Miyazaki, T. Nishino, S. Nakayamada, Y. Tanaka
Journal: Annals of the Rheumatic Diseases
Year: 2025

Article: Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study
Authors: N. Okamoto, T.A. Atsumi, M. Takagi, Y. Tanaka, M. Kuwana
Journal: Modern Rheumatology
Year: 2025

Article: Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus
Authors: Y. Fujita, S. Nakayamada, S. Kubo, H. Tanaka, Y. Tanaka
Journal: RMD Open
Year: 2025

Article: Time trends of variability in disease activity in systemic lupus erythematosus
Authors: N. Li, A.Y.B. Hoi, S.F. Luo, R.K. Kandane-Rathnayake, E.F. Morand
Journal: Lupus Science and Medicine
Year: 2025

Article: The Uncoupling of Disease Activity from Joint Structural Progression in Patients with Rheumatoid Arthritis Treated with Filgotinib
Authors: Y. Tanaka, T.A. Atsumi, D. Aletaha, C. Watson, T. Takeuchi
Journal: Rheumatology and Therapy
Year: 2025

Meilang Xue | Medicine and Dentistry | Best Researcher Award

Posted on 27/03/202527/03/2025 by Book of Award

Assoc. Prof. Dr. Meilang Xue | Medicine and Dentistry | Best Researcher Award

University of Sydney | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Assoc. Prof. Dr. Meilang Xue embarked on her academic journey with a strong passion for biomedical sciences. She earned her PhD from the University of New South Wales in 2002, laying the foundation for a distinguished career in molecular and cellular research. Her early academic years were marked by an inquisitive drive to uncover the intricate mechanisms of inflammatory and autoimmune diseases, setting the stage for groundbreaking discoveries in the field.

Professional Endeavors 🏢

Dr. Xue is currently the Head of the Sutton Arthritis Research Laboratory and the Chief Scientist of the A3BC Biobank at the Institute of Bone & Joint Research, Kolling Institute, University of Sydney. Since joining the Sutton Lab after her PhD, she has been instrumental in advancing the understanding of inflammatory and autoimmune diseases. Her leadership in these roles has facilitated significant research collaborations and the translation of scientific findings into potential therapeutic applications.

Contributions and Research Focus 🔬

Dr. Xue's research primarily explores the molecular and cellular mechanisms underpinning inflammatory and autoimmune conditions. She was the first to elucidate the critical role of the endothelial protein C receptor (EPCR) and its anti-clotting properties within the synovial joint and skin. These discoveries have revolutionized the understanding of rheumatoid arthritis, skin inflammation, and even type 1 diabetes. Her research has been widely recognized in high-impact journals such as Ann Rheum Dis, Arthritis Rheum, Rheumatology, and Journal of Investigative Dermatology. With 92 publications, 25 patents, and over 6,200 citations, her work has significantly contributed to medical science.

Accolades and Recognition 🏆

Dr. Xue's exemplary contributions have earned her numerous prestigious research fellowships and grants exceeding $5 million, funded by the NHMRC, Arthritis Australia, Lincoln Centre, JDRF International, and industry partners. She has been ranked as the 12th world-leading expert in endothelial protein C receptor research, placing her in the top 0.67% of published authors worldwide in this domain. Her h-index of 37 further underscores her influential impact on the field.

Impact and Influence 🌍

Beyond her research, Dr. Xue has played a crucial role in fostering the next generation of scientists. She has mentored and supervised numerous PhD candidates, postdoctoral fellows, honors students, and research assistants. As a committee member of the Kolling Institute’s Musculoskeletal Priority Research Area Leadership Group and the Kolling Research Enabler Group, she continues to shape the direction of musculoskeletal research. Additionally, her work with the A3BC as a Steering Committee member and chief scientist since 2017 has strengthened national and international research collaborations.

Legacy and Future Contributions 📚

Dr. Xue's dedication to scientific excellence ensures a lasting legacy in inflammatory and autoimmune disease research. Her ongoing studies into the protein C system’s role in disease modulation continue to inspire new therapeutic strategies. With her leadership in academia and industry collaborations, she is set to drive further advancements in precision medicine. Her unwavering commitment to research, mentorship, and innovation cements her reputation as a trailblazer in the field of molecular medicine.

Publications

📄 Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis
Author(s): Meilang Xue, Lyn March
Journal: Cells
Year: 2025

📄 EPCR Deficiency Ameliorates Inflammatory Arthritis in Mice by Suppressing the Activation and Migration of T Cells and Dendritic Cells
Author(s): Meilang Xue, Haiyan Lin, Hai Po Helena Liang, Christopher John Jackson, L. M. March
Journal: Rheumatology (United Kingdom)
Year: 2024

📄 Exploring the Association Between Circulating Endothelial Protein C Receptor and Disease Activity of Rheumatoid Arthritis in a Pilot Study
Author(s): Meilang Xue, Haiyan Lin, Tom Lynch, Mihir Dilip Wechalekar, L. M. March
Journal: Rheumatology Advances in Practice
Year: 2024

📄 Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model
Author(s): Meilang Xue, Christopher John Jackson, Haiyan Lin, John H. Griffin, L. M. March
Journal: International Journal of Molecular Sciences
Year: 2024

📄 Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing
Author(s): Sohel M. Julovi, Kelly J. McKelvey, Nikita Minhas, Meilang Xue, Christopher John Jackson
Journal: International Journal of Molecular Sciences
Year: 2024

Guoxin Ni | Medicine and Dentistry | Best Researcher Award

Posted on 26/03/202526/03/2025 by Book of Award

Prof. Guoxin Ni | Medicine and Dentistry | Best Researcher Award

First Affiliated Hospital of Xiamen University | China

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Prof. Guoxin Ni embarked on his academic journey with a strong foundation in [specific field], earning his [degree] from [university] in [year]. His early years were marked by an insatiable curiosity and dedication to understanding [relevant subject], which laid the groundwork for his future contributions to academia and research.

🌟 Professional Endeavors

Over the years, Prof. Ni has been associated with esteemed institutions such as [institution names], where he has played a pivotal role in [teaching/research]. As a [current position] at [university/institution], he has been instrumental in shaping the academic landscape, mentoring students, and spearheading research initiatives that push the boundaries of [field of expertise].

🔬 Contributions and Research Focus

Prof. Ni’s research is centered on [key research areas], where he has made groundbreaking discoveries in [specific topic]. His work on [notable research or project] has been widely recognized, contributing significantly to the advancement of [industry/academic field]. His innovative approaches and methodologies have paved the way for new understandings and applications in [related domain].

🏆 Accolades and Recognition

A recipient of numerous awards, Prof. Ni’s excellence has been acknowledged through [list of notable awards and honors]. His contributions have been celebrated in [journals/conferences], and he continues to be a sought-after speaker and expert in his field.

🌐 Impact and Influence

Beyond academia, Prof. Ni has influenced the broader [industry/field] community through collaborations with [organizations/industries]. His work has inspired budding researchers and professionals alike, setting new benchmarks for innovation and excellence. His leadership in [specific initiative or research group] has fostered a culture of exploration and intellectual growth.

💪 Legacy and Future Contributions

Looking ahead, Prof. Ni remains committed to advancing research in [field], with ongoing projects aimed at [future research direction]. His vision and dedication continue to drive progress, ensuring a lasting legacy in both academic and professional circles. His impact will undoubtedly shape the future of [industry or field] for generations to come.

Publications

📄 Mechanosensitive lncRNA H19 promotes chondrocyte autophagy, but not pyroptosis, by targeting miR-148a in post-traumatic osteoarthritis
Authors: Xuchang Zhou, Hong Cao, Tao Liao, Shengyao Liu, Guoxin Ni
Journal: Non-coding RNA Research
Year: 2025

📄 Antioxidant taurine inhibits chondrocyte ferroptosis through upregulation of OGT/Gpx4 signaling in osteoarthritis induced by anterior cruciate ligament transection
Authors: Xuchang Zhou, Yajing Yang, Xu Qiu, Donghai Lin, Guoxin Ni
Journal: Journal of Advanced Research
Year: 2025

📄 Translation, Cross-Culture Adaptation and Measurement Properties of the Simplified Chinese Version of the Osteoarthritis Knowledge Scale
Authors: Ziru Wang, Ben Darlow, Huili Deng, Guoxin Ni
Journal: Musculoskeletal Care
Year: 2024

📄 Tetrathiomolybdate alleviates osteoporosis by activating the PI3K/AKT signaling axis
Authors: Xuchang Zhou, C.H. Cao, Dongxue Wang, Shengyao Liu, Guoxin Ni
Journal: European Cells and Materials
Year: 2024

📄 Evaluation of Quantitative and Selective Sensory Fiber Dysfunction in Patients with Cirrhosis
Authors: Nannan Zhang, Zhiyong Wang, Jianmin Chen, Guoxin Ni, Jun Ni
Journal: Current Neurovascular Research
Year: 2024

Jeong A Kim | Medicine and Dentistry | Best Researcher Award

Posted on 25/02/202525/02/2025 by Book of Award

Prof. Jeong A Kim | Medicine and Dentistry | Best Researcher Award

St. Vincent Hospital, The Catholic University of Korea | South Korea

Author Profile

Scopus

Early Academic Pursuits ✨

Prof. Jeong A Kim embarked on an illustrious academic journey in the field of medicine, laying a solid foundation at the Catholic University Medical College. She completed her premedical course in 1986, followed by earning her Doctor of Medicine degree in 1990. Her passion for internal medicine and hematology led her to pursue advanced studies at The Catholic University of Korea, where she obtained a Master’s degree in 1998 and a Ph.D. in 2001. This strong academic background established her as a dedicated scholar committed to the advancement of medical sciences.

Professional Endeavors 🏥

Prof. Kim's professional career began with rigorous postdoctoral training. She completed her internship at St. Mary’s Hospital in 1991, followed by a residency in Internal Medicine at Catholic University Medical College until 1995. She further honed her expertise in hemato-oncology through a fellowship at Samsung Medical Center. Her international exposure expanded when she joined the Department of Microbiology and Immunology at IUPUI, USA, as a postdoctoral researcher. Her academic appointments at The Catholic University of Korea saw a steady rise, from Instructor in 1997 to Assistant Professor in 2001, Associate Professor in 2009, and finally attaining the prestigious title of Professor of Internal Medicine in 2014. In parallel, she has been a dedicated physician at St. Vincent Hospital since 1997 and has been leading the hematology and stem cell transplantation center since 2018.

Contributions and Research Focus 📝

Prof. Kim has made groundbreaking contributions in hematology and oncology, with a primary focus on stem cell transplantation, multiple myeloma, and lymphoma. Her extensive clinical trials and research studies have played a pivotal role in developing new treatment modalities for hematologic malignancies. Her work in targeted therapies, chemotherapy combinations, and immunotherapy has significantly improved patient outcomes and quality of life. She has been involved in more than 60 clinical trials, evaluating novel drug efficacy and safety, including studies on Zoledronic acid for multiple myeloma, targeted treatments like Dasatinib for leukemia, and the role of rituximab in lymphoma. Her research has also delved into prognostic factors, precision medicine, and innovative therapeutic strategies for refractory and relapsed hematologic diseases.

Accolades and Recognition 🏆

Prof. Kim's relentless pursuit of excellence has earned her recognition from esteemed medical institutions and societies. As a member of the Korean Association of Internal Medicine, the Korean Hematology Association, and the American Hematology Association, she has played an instrumental role in shaping global hematologic research. Her contributions have been acknowledged through numerous awards, invitations as a keynote speaker, and influential publications in high-impact medical journals.

Impact and Influence ✨

With a career spanning decades, Prof. Kim has mentored numerous young medical professionals, guiding them in clinical research and evidence-based medical practice. Her work has directly influenced hematologic treatment protocols in Korea and internationally. Her leadership in hematology and stem cell transplantation has set new benchmarks in patient care and innovative treatment approaches.

Legacy and Future Contributions 🌟

Prof. Jeong A Kim's legacy is deeply ingrained in the advancements of hematology and oncology. Her dedication to research, patient care, and education continues to inspire the next generation of medical professionals. Looking ahead, she remains committed to pioneering more targeted therapies, enhancing stem cell transplantation techniques, and improving long-term survival rates for hematologic malignancy patients. With ongoing research and collaborations, she is poised to make even greater strides in the field, leaving an indelible mark on medical science and patient care.

Publications

📄 The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma
Authors: H. Cho, J. Kim, Y. Park, Y. Kim, J. Kim, Jeong-ah
Journal: Leukemia Research
Year: 2025

📄 Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Authors: N.L. Bartlett, U.H. Hahn, W. Kim, F. Jie, J. Kim, Jeong-ah
Journal: Journal of Clinical Oncology
Year: 2025

📄 Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Authors: D. Shin, S. Park, E. Jang, W. Lee, D. Kim
Journal: Leukemia Research
Year: 2024

📄 Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Authors: H.Y. Yhim, Y. Park, J. Kim, Jeong-ah, D. Yang, J. Kwak
Journal: The Korean Journal of Internal Medicine
Year: 2024

Zhihan Zhu | Medicine and Dentistry | Best Researcher Award

Posted on 28/01/202528/01/2025 by Book of Award

Ms. Zhihan Zhu | Medicine and Dentistry | Best Researcher Award

Department of Burn and Plastic Surgery, The First People’s Hospital of Changzhou | China

Author Profile

Scopus

🎓 Early Academic Pursuits

Ms. Zhihan Zhu pursued her Bachelor’s degree at Nantong University, focusing on Clinical Medicine with a specialization in oncology. Her academic excellence earned her scholarships for three consecutive years, reflecting her dedication and outstanding performance throughout her studies. For her Master’s studies, she specialized in Burn and Plastic Surgery at Nantong University’s Xinglin College. Her education also included robust foundational courses in internal medicine, surgery, obstetrics, pediatrics, pathology, and anatomy.

🏥 Professional Endeavors

Ms. Zhu gained substantial clinical experience through internships and residencies at renowned hospitals, including the Jiangsu Provincial Yangzhou Jiangdu People's Hospital and Shanghai Minhang District Oncology Hospital. She excelled in surgical operations, patient management, and medical communication. Her expertise spans advanced techniques like autologous skin grafting, deep vein catheterization, and burn wound management. She also possesses proficiency in clinical documentation, prescription optimization, and patient interaction.

🧪 Contributions and Research Focus

Ms. Zhu’s research focuses on wound healing, tissue regeneration, and therapeutic advancements. Her notable projects include:

Developing biomimetic nanoparticles for targeted drug delivery in burn treatment.
Exploring the protective effects of artemisinin derivatives on liver damage post-burn injury.
Investigating adipose-derived stem cells in scar regeneration.

Her work has led to multiple scholarly publications as a primary or co-author, contributing significantly to advancements in burn surgery and regenerative medicine.

🏆 Accolades and Recognition

Ms. Zhu’s academic journey is marked by numerous honors, including the Master's Research Scholarship at Nantong University for three consecutive years. Her research contributions have been recognized by peers in the scientific community, reflecting her dedication and impact.

🌍 Impact and Influence

Ms. Zhu’s work in innovative surgical techniques and regenerative therapies is improving patient outcomes in burn care. Her ability to integrate clinical expertise with cutting-edge research demonstrates her influence in shaping future medical practices in her field.

🌟 Legacy and Future Contributions

With her strong foundation in clinical medicine and pioneering research, Ms. Zhu is poised to leave a lasting legacy in burn and plastic surgery. Her commitment to academic excellence and patient care will undoubtedly lead to transformative advancements in medicine.

Publications

📝Chitooligosaccharides promote diabetic wound healing by mediating fibroblast proliferation and migration

Authors: Li, Z., Zhang, C., Wang, L., Zhou, Y., Zhang, Y.
Journal: Scientific Reports
Year: 2025,

📝Application of minimally invasive debridement for deep second-degree facial burns in the early postburn phase

Authors: Zhang, C., Li, Z., Zhang, Q., Hu, K., Zhang, Y.
Journal: BMC Surgery
Year: 2025

📝Biomimetic nanoparticles of platelet membranes carrying bFGF and VEGFA genes promote deep burn wound healing

Authors: Wang, B., Chen, J., Zhang, C., Zhang, Y., Jiang, Y.
Journal: International Immunopharmacology
Year: 2023

📝Effect of stem cell treatment on burn wounds: A systemic review and a meta-analysis

Authors: Qiao, Y., Zhang, Q., Peng, Y., Li, Z., Zhang, Y.
Journal: International Wound Journal
Year: 2023

📝Identification of nanoparticle-mediated siRNA-ASPN as a key gene target in the treatment of keloids

Authors: Dong, Y., Zhang, C., Zhang, Q., Gu, H., Zhang, Y.
Journal: Frontiers in Bioengineering and Biotechnology
Year: 2022

Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Posted on 18/09/202418/09/2024 by Book of Award

Dr. Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Seoul National University College of Medicine | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Dong Hyun Kim embarked on his medical journey at the prestigious Seoul National University College of Medicine, earning his Bachelor of Medicine in 2019. His academic rigor continued with a Master's degree in Medical Science, specializing in Translational Medicine, which he completed in 2024. His academic training laid the foundation for his future endeavors in clinical oncology and hematologic malignancies, blending medicine with cutting-edge research.

Professional Endeavors 🏥

Dr. Kim's professional career began at Seoul National University Hospital, where he completed his internship and then advanced to a Resident Doctor position in the Department of Internal Medicine. His expertise expanded into the field of Hemato-Oncology, where he currently serves as an External Clinical Researcher. His clinical work, especially in the realm of cancer treatment and translational medicine, has contributed significantly to patient care and scientific discovery.

Contributions and Research Focus 🔬

Dr. Kim’s research has made a considerable impact on hematologic malignancies and the use of artificial intelligence in oncology. His work spans various domains, including allogeneic stem cell transplantation, tumor-infiltrating lymphocytes as biomarkers, and predictive modeling in cancer treatment. Through his numerous publications, he has explored innovative treatments and personalized medicine, particularly focusing on improving patient outcomes in myelofibrosis, thymic epithelial neoplasms, and head and neck squamous cell carcinoma.

Accolades and Recognition 🏅

Dr. Kim has received numerous awards that underscore his contributions to the field. He earned the Best Oral Presentation Award at ICBMT 2022, a Presidential Oral Presentation at JSMO 2024, and another Best Oral Presentation Award at ICKSH 2024. These recognitions reflect his leadership in oncology research and his ability to present complex ideas with clarity and authority.

Impact and Influence 🌍

Through his published works, Dr. Kim has influenced the global oncology community. His research on artificial intelligence in oncology, predictive biomarkers, and innovative therapeutic approaches has opened new pathways in cancer treatment. His contributions, especially in improving treatment strategies for hematologic malignancies and solid tumors, are helping shape the future of personalized medicine.

Legacy and Future Contributions 🌟

Dr. Kim is poised to continue influencing the fields of clinical oncology and translational medicine. His dedication to research, combined with his clinical expertise, ensures that he will remain a key figure in advancing cancer treatment and improving patient outcomes. His future endeavors, backed by a solid academic and professional foundation, are expected to further elevate the standards of oncological care and research.

Publications

📄 Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation
Author: Kim, D.H., Shin, D.-Y., Koh, Y., Byun, J.M., Hong, J.
Journal: Scientific Reports
Year: 2024

📄 Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea
Author: Kim, D.H., Youk, J., Byun, J.M., Yoo, S.H., Shin, D.-Y.
Journal: European Journal of Haematology
Year: 2024

📄 Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
Author: Kim, D.H., Lim, S.T., Kim, H.R., Shin, S.-H., Yun, H.J.
Journal: Oral Oncology
Year: 2024

📄 Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma
Author: Kim, D.H., Lim, Y., Ock, C.-Y., Kim, S.-B., Keam, B.
Journal: Head and Neck
Year: 2023

Bin Hu | Medicine and Dentistry | Best Researcher Award

Posted on 18/04/202418/04/2024 by Book of Award

Mr. Bin Hu | Medicine and Dentistry | Best Researcher Award

Hubei University of Technology | China

Author Profile

Scopus

Early Academic Pursuits

Bin Hu embarked on his academic journey at Hubei University of Technology, specializing in computer vision. During his undergraduate studies, he demonstrated exceptional promise by authoring three papers, including a groundbreaking cell nucleus segmentation method published in a prestigious journal.

Professional Endeavors

Currently pursuing graduate studies, Bin Hu has amassed over 7 years of experience in computer vision. He has led research projects during his postgraduate studies and actively contributed to multidisciplinary collaborations, showcasing his ability to tackle diverse challenges.

Contributions and Research Focus

Bin Hu's research focuses on computer vision, with a particular emphasis on developing advanced segmentation methods for medical imaging. His recent work introduces the Double-stage Codec Attention Network, a novel approach for accurate nucleus segmentation from tissue images. This method leverages hierarchical feature extraction, feature selection units, and multi-scale deep feature fusion to achieve superior segmentation performance.

Accolades and Recognition

Bin Hu's contributions have garnered recognition both nationally and internationally. He holds two national patents for inventions in his field and has presented his research at esteemed conferences such as IEEE Transactions on Medical Imaging. His pioneering work has earned him awards and recognition.

Impact and Influence

Bin Hu's research has significant implications for clinical applications, particularly in the field of medical imaging. His innovative segmentation methods, such as DSCA-Net, outperform state-of-the-art models and demonstrate excellent efficiency in generating predictive images. His contributions have the potential to advance the field of computer vision and improve medical diagnosis and treatment.

Legacy and Future Contributions

Bin Hu's expertise in computer vision and his practical problem-solving skills position him as a valuable contributor to innovative projects in both academic and industrial settings. His dedication to advancing research in medical imaging underscores his commitment to making meaningful contributions to society. As he continues his academic and professional journey, Bin Hu aims to further expand his research portfolio and drive advancements in computer vision technology.

Notable Publications

Focus Stacking with High Fidelity and Superior Visual Effects 2024

Ao Gu | Medicine and Dentistry | Best Researcher Award

Posted on 22/02/202422/02/2024 by Book of Award

Dr. Ao Gu | Medicine and Dentistry | Best Researcher Award

Shanghai Jiao Tong University School of Medicine | China

Author profile

Scopus

Early Academic Pursuits

Dr. Ao Gu completed his M.B in Clinical Medicine at Hebei University Health Science Center and is pursuing a master's degree at Shanghai Jiao Tong University School of Medicine, focusing on antitumor-active molecules under Prof. Yingbin Liu's mentorship.

Professional Endeavors

With a background in Clinical Medicine, Dr. Gu's professional journey includes extensive research in therapeutic molecules. He actively contributes to the scientific community through his publications and ongoing academic pursuits.

Contributions and Research Focus

Dr. Gu's research primarily centers on exploring the therapeutic capabilities of antitumor-active molecules. His work spans various aspects of medicine and chemistry, ranging from patient-derived models to single-cell omics analysis.

Accolades and Recognition

Dr. Ao Gu has gained recognition for his significant contributions to the field, as evidenced by his publications in reputable scientific journals. His work has been acknowledged for its innovation and potential impact on cancer research.

Impact and Influence

Through his research, Dr. Gu has the potential to influence advancements in cancer treatment and therapeutic molecule development. His contributions add valuable insights to the scientific community's understanding of antitumor agents.

Legacy and Future Contributions

Dr. Ao Gu's legacy lies in his dedication to advancing medical knowledge and developing novel therapeutic approaches. His future contributions are anticipated to further enrich the field of oncology and inspire aspiring researchers in the pursuit of medical excellence.

Notable Publications

Six-Membered Aromatic Nitrogen Heterocyclic Anti-Tumor Agents: Synthesis and Applications 2023

Aggregation-enabled alkene insertion into carbon–halogen bonds 2023 (1)

Solvent-free and Catalyst-free Direct Alkylation of Alkenes 2023 (1)

Trisubstituted alkenes featuring aryl groups: stereoselective synthetic strategies and applications 2023 (3)

Oksana Boyarchuk | Medicine and Dentistry | Best Researcher Award

Posted on 16/02/202421/08/2024 by Book of Award

Prof. Oksana Boyarchuk | Medicine and Dentistry | Best Researcher Award

I.Horbachevsky Ternopil National Medical University | Ukraine

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Prof. Oksana Boyarchuk embarked on her academic journey at Ternopil State Medical Institute, where she pursued her specialty in medical affairs, earning her diploma in 1994. She later attained her Doctor of Medical Science degree with a specialization in pediatrics from I.Horbachevsky Ternopil State Medical University in 2013.

Professional Endeavors

Her professional career has been marked by significant roles and responsibilities. From 2008 to 2014, she served as an Associate Professor at the Department of Pediatric Diseases, Faculty of Postgraduate Education, I. Horbachevsky Ternopil State Medical University. Subsequently, she assumed the position of Dean of the Medical Faculty from 2014 to 2016. Since September 2016, she has been the Head of the Department of Children’s Diseases and Pediatric Surgery at I.Horbachevsky Ternopil National Medical University.

Contributions and Research Focus

Prof. Boyarchuk has been actively involved in various research projects, particularly in the field of pediatric immunodeficiency diseases and the psychological well-being of children, including those affected by long COVID-19. Her endeavors include management and participation in research projects funded by both national and international institutions.

Accolades and Recognition

Her contributions to the field of pediatric medicine have earned her recognition and accolades, including certificates from the Ternopil Regional State Administration and Council for her conscientious work, professionalism, and significant achievements in scientific and educational domains.

Impact and Influence

Prof. Boyarchuk's research and academic leadership have had a profound impact on the medical community, especially in the diagnosis and management of pediatric diseases. Her involvement in international collaborations and participation in research initiatives aimed at addressing pressing healthcare challenges further underscores her influence in the field.

Legacy and Future Contributions

As a distinguished professor in pediatrics, Prof. Boyarchuk continues to leave a lasting legacy through her research, teaching, and mentorship. Her commitment to advancing pediatric healthcare and her pursuit of innovative solutions to improve child well-being position her as a leading figure in the medical community, with promising contributions to come in the future.

Notable Publications

The Impact of the Russian Invasion on Healthcare of Patient with Inborn Errors of Immunity and on the Professional Activity of Immunologists in Ukraine 2023 (1)

Determining the Number of TREC and KREC Copies for Screening of Inborn Errors of Immunity 2023 (1)

Assessment of awareness regarding the diagnosis and management of pharyngitis in children among general practitioners 2023

A patient-centered care for the management of children with rare diseases: collaboration between physicians, nurses, and patients 2023

Christian Pfister | Medicine and Dentistry | Excellence in Research Award

Posted on 25/01/202425/01/2024 by Book of Award

Prof. Christian Pfister | Medicine and Dentistry | Excellence in Research Award

Rouen University Hospital | France

Author Profile

Scopus

Early Academic Pursuits

Prof. Christian Pfister's academic journey commenced with a focus on urology at Charles Nicolle University Hospital in Rouen, France. His early academic pursuits involved comprehensive studies in urological sciences, laying the foundation for a distinguished career in the medical field.

Professional Endeavors

Having established himself as a prominent figure in the field of urology, Prof. Christian Pfister has been associated with the Rouen University Hospital in France. His professional endeavors encompass a wide array of responsibilities within the Department of Urology, where he contributes to patient care, education, and research initiatives.

Contributions and Research Focus

Prof. Pfister's contributions extend beyond clinical practice, with a significant focus on urological research. His research endeavors likely involve advancements in urological treatments, surgical techniques, and potentially groundbreaking discoveries that contribute to the broader medical community's knowledge and understanding.

Accolades and Recognition

Prof. Christian Pfister has likely received accolades and recognition for his outstanding contributions to urology. Recognition may come in the form of awards, honors, or appointments to leadership positions within medical societies, acknowledging his expertise and impact on the field.

Impact and Influence

Prof. Pfister's impact is evident in his influence on the practice of urology, both locally within Rouen University Hospital and potentially on a broader scale. Through his clinical expertise, research contributions, and potential leadership roles, he likely plays a pivotal part in shaping urological practices and advancements.

Legacy and Future Contributions

As a seasoned professional in the field, Prof. Christian Pfister is likely building a lasting legacy in urology. His current contributions, coupled with his dedication to education and patient care, suggest a commitment to leaving a lasting impact on the field. His future contributions may involve mentoring the next generation of urologists and further advancing urological knowledge and treatments.

Notable Publications

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study 2023 (1)

Differential impact of COVID-19 on urological surgeries in public and private institutions between 2019 and 2021 in France | Impact du COVID-19 sur l'activité chirurgicale urologique dans les établissements de santé publics et privés entre 2019 et 2021 en France 2023 (1)

Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial 2023 (4)